Infection and Immunity, July 1994, p. 2825-2833, Vol. 62, No. 7
0019-9567/1994/$04.00+0 DOI:
Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.
L C Lim,
D M England,
B K DuChateau,
N J Glowacki,
J R Creson,
S D Lovrich,
S M Callister,
D A Jobe, and
R F Schell
Wisconsin State Laboratory of Hygiene, Madison 53706.
ABSTRACT
We present the first direct evidence that adverse effects, particularly severe destructive arthritis, can develop in vaccinated hamsters after challenge with Borrelia burgdorferi sensu lato isolates. Hamsters were vaccinated with a whole-cell preparation of Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 in adjuvant. A severe destructive arthritis was readily evoked in vaccinated hamsters challenged with the homologous B. burgdorferi sensu stricto isolate C-1-11 before high levels of protective borreliacidal antibody developed. Once high levels of C-1-11 borreliacidal antibody developed, hamsters were protected from homologous challenge and development of arthritis. Vaccinated hamsters, however, still developed severe destructive arthritis when challenged with other isolates of the three genomic groups of B. burgdorferi sensu lato (B. burgdorferi sensu stricto isolate 297, Borrelia garinii isolate LV4, and Borrelia afzelii isolate BV1) despite high levels of C-1-11 specific borreliacidal antibody. Vaccines that contained whole spirochetes in adjuvant induced destructive arthritis, but this effect was not dependent on the isolate of B. burgdorferi sensu lato or the type of adjuvant. These studies demonstrate that caution is necessary when employing whole spirochetes in adjuvant for vaccination to prevent Lyme borreliosis. Additional studies are needed to identify the antigen(s) responsible for the induction and activation of arthritis and to define the immune mechanisms involved.
Infection and Immunity, July 1994, p. 2825-2833, Vol. 62, No. 7
0019-9567/1994/$04.00+0 DOI:
This article has been cited by other articles:
-
Nardelli, D. T., Callister, S. M., Schell, R. F.
(2008). Lyme Arthritis: Current Concepts and a Change in Paradigm. CVI
15: 21-34
[Full Text]
-
Peterson, S. H., Nardelli, D. T., Warner, T. F., Callister, S. M., Torrealba, J. R., Schell, R. F.
(2007). Anti-p19 Antibody Treatment Exacerbates Lyme Arthritis and Enhances Borreliacidal Activity. CVI
14: 510-517
[Abstract]
[Full Text]
-
Nardelli, D. T., Warner, T. F., Callister, S. M., Schell, R. F.
(2006). Anti-CD25 Antibody Treatment of Mice Vaccinated and Challenged with Borrelia spp. Does Not Exacerbate Arthritis but Inhibits Borreliacidal Antibody Production.. CVI
13: 884-891
[Abstract]
[Full Text]
-
Amlong, C. A., Nardelli, D. T., Peterson, S. H., Warner, T. F., Callister, S. M., Schell, R. F.
(2006). Anti-Interleukin-15 Prevents Arthritis in Borrelia-Vaccinated and -Infected Mice. CVI
13: 289-296
[Abstract]
[Full Text]
-
Nardelli, D. T., Burchill, M. A., England, D. M., Torrealba, J., Callister, S. M., Schell, R. F.
(2004). Association of CD4+ CD25+ T Cells with Prevention of Severe Destructive Arthritis in Borrelia burgdorferi-Vaccinated and Challenged Gamma Interferon-Deficient Mice Treated with Anti-Interleukin-17 Antibody. CVI
11: 1075-1084
[Abstract]
[Full Text]
-
Munson, E. L., DeCoster, D. J., Nardelli, D. T., England, D. M., Callister, S. M., Schell, R. F.
(2004). Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice. CVI
11: 35-41
[Abstract]
[Full Text]
-
Burchill, M. A., Nardelli, D. T., England, D. M., DeCoster, D. J., Christopherson, J. A., Callister, S. M., Schell, R. F.
(2003). Inhibition of Interleukin-17 Prevents the Development of Arthritis in Vaccinated Mice Challenged with Borrelia burgdorferi. Infect. Immun.
71: 3437-3442
[Abstract]
[Full Text]
-
Christopherson, J. A., Munson, E. L., England, D. M., Croke, C. L., Remington, M. C., Molitor, M. L., DeCoster, D. J., Callister, S. M., Schell, R. F.
(2003). Destructive Arthritis in Vaccinated Interferon Gamma-Deficient Mice Challenged with Borrelia burgdorferi: Modulation by Tumor Necrosis Factor Alpha. CVI
10: 44-52
[Abstract]
[Full Text]
-
Munson, E. L., Du Chateau, B. K., Jensen, J. R., Callister, S. M., DeCoster, D. J., Schell, R. F.
(2002). Gamma Interferon Inhibits Production of Anti-OspA Borreliacidal Antibody In Vitro. CVI
9: 1095-1101
[Abstract]
[Full Text]
-
Parenti, D. L., Schell, R. F., Callister, S. M., Lovrich, S. D.
(2000). Outer Surface Protein A and Arthritis in Hamsters. Infect. Immun.
68: 7212-7213
[Full Text]
-
Munson, E. L., Du Chateau, B. K., Jobe, D. A., Lovrich, S. D., Callister, S. M., Schell, R. F.
(2000). Production of Borreliacidal Antibody to Outer Surface Protein A In Vitro and Modulation by Interleukin-4. Infect. Immun.
68: 5496-5501
[Abstract]
[Full Text]
-
Croke, C. L., Munson, E. L., Lovrich, S. D., Christopherson, J. A., Remington, M. C., England, D. M., Callister, S. M., Schell, R. F.
(2000). Occurrence of Severe Destructive Lyme Arthritis in Hamsters Vaccinated with Outer Surface Protein A and Challenged with Borrelia burgdorferi. Infect. Immun.
68: 658-663
[Abstract]
[Full Text]
-
Di Genaro, M. S., Munoz, E., Aguilera, C., de Guzman, A. M. S.
(2000). Yersinia enterocolitica O:8 and O:5 lipopolysaccharide arthritogenicity in hamsters. Rheumatology (Oxford)
39: 73-78
[Abstract]
[Full Text]
-
Jensen, J. R., Du Chateau, B. K., Munson, E. L., Callister, S. M., Schell, R. F.
(1998). Inhibition of the Production of Anti-OspA Borreliacidal Antibody with T Cells from Hamsters Vaccinated against Borrelia burgdorferi. Infect. Immun.
66: 1507-1512
[Abstract]
[Full Text]
-
Straubinger, R. K., Straubinger, A. F., Summers, B. A., Erb, H. N., Harter, L., Appel, M. J. G.
(1998). Borrelia burgdorferi Induces the Production and Release of Proinflammatory Cytokines in Canine Synovial Explant Cultures. Infect. Immun.
66: 247-258
[Abstract]
[Full Text]
Copyright © 1994 by the American Society for Microbiology. All rights reserved.